To further evaluate the expression of LRP4 as a prognostic marker in patient treated by chemotherapy we used a series of 405 triplenegative breast cancers (TNBC) with matched gene expression and clinical data extracted from 7830 unique samples across 55 independent datasets 26. The gene discussed is LRP4; the disease is breast cancer.